{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T05:48:32Z","timestamp":1746078512138,"version":"3.37.3"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100007834","name":"Ningbo Natural Science Foundation","doi-asserted-by":"publisher","award":["2018A610253","2018A610384"],"award-info":[{"award-number":["2018A610253","2018A610384"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004387","name":"K.C. Wong Magna Fund in Ningbo University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004387","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Cancer Institute Intramural Research Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Metabolic syndrome (MS) is the concurrence of at least three of five medical conditions: obesity, high blood pressure, insulin resistance, high serum triglyceride (TG) and low serum high-density lipoprotein levels. While fibrates are used to treat disorders other than the lowering serum TG, the mechanism by which fibrates decrease MS has not been established.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this study, wild-type and Ppara-null mice fed a medium-fat diet (MFD) were administered gemfibrozil and fenofibrate for 3 months respectively, to explore the effect and action mechanism.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>In Ppara-null mice, MFD treatment increased body weight, adipose tissue, serum TG and impaired glucose tolerance. These phenotypes were attenuated in two groups treated with gemfibrozil and fenofibrate. The STAT3 pathway was activated in adipose and hepatic tissues in positive control, and inhibited in groups treated with gemfibrozil and fenofibrate. The above phenotypes and inflammation were not observed in any wild-type group. In 3T3-L1 adipogenic stem cells treated with high glucose, STAT3 knockdown greatly decreased the number of lipid droplets.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Low dose of clinical fibrates was effective against MS development independent of PPAR\u03b1, and this action was mediated by STAT3 signalling inhibition in adipose tissue and, to a lesser extent, in hepatic tissues.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/jphp.13014","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T07:44:20Z","timestamp":1537861460000},"page":"1630-1642","source":"Crossref","is-referenced-by-count":10,"title":["PPAR\u03b1-independent action against metabolic syndrome development by fibrates is mediated by inhibition of STAT3 signalling"],"prefix":"10.1093","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4443-2019","authenticated-orcid":false,"given":"Huiying","family":"Hua","sequence":"first","affiliation":[{"name":"Medical School of Ningbo University , Ningbo,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julin","family":"Yang","sequence":"additional","affiliation":[{"name":"Ningbo College of Health Sciences , Ningbo,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hante","family":"Lin","sequence":"additional","affiliation":[{"name":"Medical School of Ningbo University , Ningbo,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Xi","sequence":"additional","affiliation":[{"name":"Medical School of Ningbo University , Ningbo,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manyun","family":"Dai","sequence":"additional","affiliation":[{"name":"Medical School of Ningbo University , Ningbo,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gangming","family":"Xu","sequence":"additional","affiliation":[{"name":"Medical School of Ningbo University , Ningbo,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Medical School of Ningbo University , Ningbo,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Liu","sequence":"additional","affiliation":[{"name":"Medical School of Ningbo University , Ningbo,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingqi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Medical School of Ningbo University , Ningbo,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[{"name":"Medical School of Ningbo University , Ningbo,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Laboratory of Metabolism, National Cancer Institute, NIH , Bethesda, MD,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiming","family":"Liu","sequence":"additional","affiliation":[{"name":"Medical School of Ningbo University , Ningbo,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,12,1]]},"reference":[{"key":"2024103012320169300_jphp13014-cit-0001","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11154-014-9298-4","article-title":"Pharmacological treatment and therapeutic perspectives of metabolic syndrome","volume":"15","author":"Lim","year":"2014","journal-title":"Rev Endocr Metab Disord"},{"key":"2024103012320169300_jphp13014-cit-0002","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2337\/dc10-0879","article-title":"Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999\u20132006","volume":"34","author":"Mozumdar","year":"2011","journal-title":"Diabetes Care"},{"key":"2024103012320169300_jphp13014-cit-0003","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"2024103012320169300_jphp13014-cit-0004","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1161\/01.CIR.0000013953.41667.09","article-title":"Prevention conference VI: diabetes and cardiovascular disease: writing group I: epidemiology","volume":"105","author":"Howard","year":"2002","journal-title":"Circulation"},{"key":"2024103012320169300_jphp13014-cit-0005","first-page":"487","article-title":"Long-term effect of rosiglitazone and\/or ramipril on the incidence of diabetes","volume":"54","author":"Investigators","year":"2010","journal-title":"Diabetologia"},{"key":"2024103012320169300_jphp13014-cit-0006","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa1010949","article-title":"Pioglitazone for diabetes prevention in impaired glucose tolerance","volume":"364","author":"Defronzo","year":"2011","journal-title":"N Engl J Med"},{"key":"2024103012320169300_jphp13014-cit-0007","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.tcb.2017.01.006","article-title":"Inflammation and the metabolic syndrome: the tissue-specific functions of NF-\u03baB","volume":"27","author":"Catrysse","year":"2017","journal-title":"Trends Cell Biol"},{"key":"2024103012320169300_jphp13014-cit-0008","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.1227568","article-title":"JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation","volume":"339","author":"Han","year":"2013","journal-title":"Science"},{"key":"2024103012320169300_jphp13014-cit-0009","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature01137","article-title":"A central role for JNK in obesity and insulin resistance","volume":"420","author":"Hirosumi","year":"2002","journal-title":"Nature"},{"key":"2024103012320169300_jphp13014-cit-0010","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1074\/jbc.M111.317453","article-title":"Hepatocyte-specific deletion of Janus kinase 2 (JAK2) protects against diet-induced steatohepatitis and glucose intolerance","volume":"287","author":"Shi","year":"2012","journal-title":"J Biol Chem"},{"key":"2024103012320169300_jphp13014-cit-0011","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1172\/JCI42894","article-title":"Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2","volume":"121","author":"Sos","year":"2011","journal-title":"J Clin Invest"},{"key":"2024103012320169300_jphp13014-cit-0012","first-page":"129","article-title":"Nonalcoholic fatty liver disease as a feature of the metabolic syndrome","volume":"58","author":"Socha","year":"2007","journal-title":"Rocz Panstw Zakl Hig"},{"key":"2024103012320169300_jphp13014-cit-0013","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1055\/s-0043-101919","article-title":"Lycopene improves insulin sensitivity through inhibition of STAT3\/Srebp-1c-mediated lipid accumulation and inflammation in mice fed a high-fat diet","volume":"125","author":"Zeng","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2024103012320169300_jphp13014-cit-0014","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1038\/nutd.2016.49","article-title":"Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway","volume":"6","author":"Chen","year":"2016","journal-title":"Nutr Diabetes"},{"key":"2024103012320169300_jphp13014-cit-0015","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/ijo.2017.208","article-title":"Foxc2 coordinates inflammation and browning of white adipose by leptin-STAT3-PRDM16 signal in mice","volume":"42","author":"Gan","year":"2018","journal-title":"Int J Obes (Lond)"},{"key":"2024103012320169300_jphp13014-cit-0016","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/ATVBAHA.108.181099","article-title":"Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosis","volume":"29","author":"MacDonald","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024103012320169300_jphp13014-cit-0017","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.atherosclerosis.2011.02.012","article-title":"Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin\/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: results from a crossover study","volume":"217","author":"Noguchi","year":"2011","journal-title":"Atherosclerosis"},{"key":"2024103012320169300_jphp13014-cit-0018","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/meta.2001.24870","article-title":"Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat","volume":"50","author":"Dana","year":"2001","journal-title":"Metab, Clin Exp"},{"key":"2024103012320169300_jphp13014-cit-0019","first-page":"205","article-title":"Gemfibrozil not fenofibrate decreases systemic glucose level via PPARalpha","volume":"71","author":"Song","year":"2016","journal-title":"Pharmazie"},{"key":"2024103012320169300_jphp13014-cit-0020","doi-asserted-by":"crossref","first-page":"16638","DOI":"10.1074\/jbc.275.22.16638","article-title":"Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity","volume":"275","author":"Guerremillo","year":"2000","journal-title":"J Biol Chem"},{"key":"2024103012320169300_jphp13014-cit-0021","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1540\/jsmr.46.125","article-title":"Evidence of direct smooth muscle relaxant effects of the fibrate gemfibrozil","volume":"46","author":"Phelps","year":"2010","journal-title":"J Smooth Muscle Res"},{"key":"2024103012320169300_jphp13014-cit-0022","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.vph.2012.01.003","article-title":"Relaxation of rat thoracic aorta by fibrate drugs correlates with their potency to disturb intracellular calcium of VSMCs","volume":"56","author":"Liu","year":"2012","journal-title":"Vascul Pharmacol"},{"key":"2024103012320169300_jphp13014-cit-0023","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1159\/000116885","article-title":"PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats","volume":"28","author":"Zhao","year":"2008","journal-title":"Am J Nephrol"},{"key":"2024103012320169300_jphp13014-cit-0024","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s00125-005-0102-6","article-title":"Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation","volume":"49","author":"Calkin","year":"2006","journal-title":"Diabetologia"},{"key":"2024103012320169300_jphp13014-cit-0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2017.03.007","article-title":"Potential role of CYP1B1 in the development and treatment of metabolic diseases","volume":"178","author":"Li","year":"2017","journal-title":"Pharmacol Ther"},{"key":"2024103012320169300_jphp13014-cit-0026","doi-asserted-by":"crossref","first-page":"41706","DOI":"10.1038\/srep41706","article-title":"Nutritional background changes the hypolipidemic effects of fenofibrate in Nile tilapia (Oreochromis niloticus)","volume":"7","author":"Ning","year":"2017","journal-title":"Sci Rep"},{"key":"2024103012320169300_jphp13014-cit-0027","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2337\/diabetes.50.12.2809","article-title":"PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance","volume":"50","author":"Guerre-Millo","year":"2001","journal-title":"Diabetes"},{"key":"2024103012320169300_jphp13014-cit-0028","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1172\/JCI11497","article-title":"PPAR\u03b1 deficiency reduces insulin resistance and atherosclerosis in apoE-null mice","volume":"107","author":"Tordjman","year":"2001","journal-title":"J Clin Invest"},{"key":"2024103012320169300_jphp13014-cit-0029","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1142\/S0192415X16500397","article-title":"Geniposide inhibits Alpha-naphthylisothiocyanate-induced intrahepatic cholestasis: the downregulation of STAT3 and NF[Formula: see text]B signaling plays an important role","volume":"44","author":"Tan","year":"2016","journal-title":"Am J Chin Med"},{"key":"2024103012320169300_jphp13014-cit-0030","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1021\/acs.jproteome.7b00838","article-title":"Targeted metabolomics reveals a protective role for basal PPARalpha in cholestasis induced by alpha-naphthylisothiocyanate","volume":"17","author":"Dai","year":"2018","journal-title":"J Proteome Res"},{"key":"2024103012320169300_jphp13014-cit-0031","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2015.09.087","article-title":"PIAS3, SHP2 and SOCS3 expression patterns in cervical cancers: relevance with activation and resveratrol-caused inactivation of STAT3 signaling","volume":"139","author":"Zhang","year":"2015","journal-title":"Gynecol Oncol"},{"key":"2024103012320169300_jphp13014-cit-0032","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cbi.2014.09.012","article-title":"Saikosaponin d protects against acetaminophen-induced hepatotoxicity by inhibiting NF-kappaB and STAT3 signaling","volume":"223","author":"Liu","year":"2014","journal-title":"Chem Biol Interact"},{"key":"2024103012320169300_jphp13014-cit-0033","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.bbrc.2016.12.042","article-title":"STAT3 stimulates adipogenic stem cell proliferation and cooperates with HMGA2 during the early stage of differentiation to promote adipogenesis","volume":"482","author":"Yuan","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"2024103012320169300_jphp13014-cit-0034","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2193-1801-3-14","article-title":"Effect of fibrate treatment on liver function tests in patients with the metabolic syndrome","volume":"3","author":"Gandhi","year":"2014","journal-title":"SpringerPlus"},{"key":"2024103012320169300_jphp13014-cit-0035","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/j.orcp.2011.03.012","article-title":"Fenofibrate ameliorates insulin resistance, hypertension and novel oxidative stress markers in patients with metabolic syndrome","volume":"5","author":"Ueno","year":"2011","journal-title":"Obes Res Clin Pract"},{"key":"2024103012320169300_jphp13014-cit-0036","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1479-5876-9-176","article-title":"Long-term fenofibrate treatment impaired glucose-stimulated insulin secretion and up-regulated pancreatic NF-kappa B and iNOS expression in monosodium glutamate-induced obese rats: is that a latent disadvantage?","volume":"9","author":"Liu","year":"2011","journal-title":"J Transl Med"},{"key":"2024103012320169300_jphp13014-cit-0037","doi-asserted-by":"crossref","first-page":"891","DOI":"10.33549\/physiolres.933304","article-title":"Hepatotoxic effects of fenofibrate in spontaneously hypertensive rats expressing human C-reactive protein","volume":"65","author":"\u0160kop","year":"2016","journal-title":"Physiol Res"},{"key":"2024103012320169300_jphp13014-cit-0038","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1111\/bph.13928","article-title":"Inhibition of JNK signalling mediates PPARalpha-dependent protection against intrahepatic cholestasis by fenofibrate","volume":"174","author":"Dai","year":"2017","journal-title":"Br J Pharmacol"},{"key":"2024103012320169300_jphp13014-cit-0039","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.2337\/db11-0174","article-title":"Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice","volume":"60","author":"Jiang","year":"2011","journal-title":"Diabetes"},{"key":"2024103012320169300_jphp13014-cit-0040","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/oby.20811","article-title":"Variations in body weight, food intake and body composition after long-term high-fat diet feeding in C57BL\/6J mice","volume":"22","author":"Yang","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"2024103012320169300_jphp13014-cit-0041","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2337\/db06-1206","article-title":"n-3 Fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor-alpha-dependent manner","volume":"56","author":"Neschen","year":"2007","journal-title":"Diabetes"},{"key":"2024103012320169300_jphp13014-cit-0042","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1194\/jlr.M027433","article-title":"Metabolomics reveals an essential role for peroxisome proliferator-activated receptor alpha in bile acid homeostasis","volume":"53","author":"Li","year":"2012","journal-title":"J Lipid Res"},{"key":"2024103012320169300_jphp13014-cit-0043","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1073\/pnas.0303992101","article-title":"Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation","volume":"101","author":"Gao","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024103012320169300_jphp13014-cit-0044","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nm980","article-title":"Role of STAT3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo","volume":"10","author":"Inoue","year":"2004","journal-title":"Nat Med"},{"key":"2024103012320169300_jphp13014-cit-0045","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1210\/en.2007-1148","article-title":"Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity","volume":"149","author":"Cernkovich","year":"2008","journal-title":"Endocrinology"},{"key":"2024103012320169300_jphp13014-cit-0046","doi-asserted-by":"crossref","first-page":"302495","DOI":"10.1155\/2012\/302495","article-title":"PPARalpha-independent arterial smooth muscle relaxant effects of PPARalpha agonists","volume":"2012","author":"Silswal","year":"2012","journal-title":"PPAR Res"},{"key":"2024103012320169300_jphp13014-cit-0047","doi-asserted-by":"crossref","first-page":"970525","DOI":"10.1155\/2012\/970525","article-title":"Peroxisome proliferator-activated receptor alpha plays an important role in the expression of monocyte chemoattractant protein-1 and neointimal hyperplasia after vascular injury","volume":"2012","author":"Peng","year":"2012","journal-title":"PPAR Res"},{"key":"2024103012320169300_jphp13014-cit-0048","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jep.2015.12.033","article-title":"Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2","volume":"179","author":"Chen","year":"2016","journal-title":"J Ethnopharmacol"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjphp.13014","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/70\/12\/1630\/60224110\/jphp13014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/70\/12\/1630\/60224110\/jphp13014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T17:43:40Z","timestamp":1730310220000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/70\/12\/1630\/6121785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,1]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jphp.13014","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"type":"print","value":"0022-3573"},{"type":"electronic","value":"2042-7158"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,12,1]]}}}